Literature DB >> 26942675

Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.

Xinjian Li1, Yuhui Jiang2, Jill Meisenhelder3, Weiwei Yang1, David H Hawke4, Yanhua Zheng1, Yan Xia2, Kenneth Aldape4, Jie He5, Tony Hunter3, Liwei Wang6, Zhimin Lu7.   

Abstract

It is unclear how the Warburg effect that exemplifies enhanced glycolysis in the cytosol is coordinated with suppressed mitochondrial pyruvate metabolism. We demonstrate here that hypoxia, EGFR activation, and expression of K-Ras G12V and B-Raf V600E induce mitochondrial translocation of phosphoglycerate kinase 1 (PGK1); this is mediated by ERK-dependent PGK1 S203 phosphorylation and subsequent PIN1-mediated cis-trans isomerization. Mitochondrial PGK1 acts as a protein kinase to phosphorylate pyruvate dehydrogenase kinase 1 (PDHK1) at T338, which activates PDHK1 to phosphorylate and inhibit the pyruvate dehydrogenase (PDH) complex. This reduces mitochondrial pyruvate utilization, suppresses reactive oxygen species production, increases lactate production, and promotes brain tumorigenesis. Furthermore, PGK1 S203 and PDHK1 T338 phosphorylation levels correlate with PDH S293 inactivating phosphorylation levels and poor prognosis in glioblastoma patients. This work highlights that PGK1 acts as a protein kinase in coordinating glycolysis and the tricarboxylic acid (TCA) cycle, which is instrumental in cancer metabolism and tumorigenesis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B-Raf; EGFR; K-Ras; PDH; PDHK1; PGK1; glycolysis; hypoxia; mitochondria; phosphorylation; tumorigenesis

Mesh:

Substances:

Year:  2016        PMID: 26942675      PMCID: PMC4888784          DOI: 10.1016/j.molcel.2016.02.009

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  40 in total

1.  Structure of the human phosphoglycerate kinase gene and the intron-mediated evolution and dispersal of the nucleotide-binding domain.

Authors:  A M Michelson; C C Blake; S T Evans; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer.

Authors:  DaoHai Zhang; Lee Kian Tai; Lee Lee Wong; Lily-Lily Chiu; Sunil K Sethi; Evelyn S C Koay
Journal:  Mol Cell Proteomics       Date:  2005-07-26       Impact factor: 5.911

3.  ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.

Authors:  Asa Kronblad; Ingrid Hedenfalk; Elise Nilsson; Sven Påhlman; Göran Landberg
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

4.  Molecular cloning and structure of an autosomal processed gene for human phosphoglycerate kinase.

Authors:  K Tani; J Singer-Sam; M Munns; A Yoshida
Journal:  Gene       Date:  1985       Impact factor: 3.688

5.  Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism.

Authors:  M B Yaffe; M Schutkowski; M Shen; X Z Zhou; P T Stukenberg; J U Rahfeld; J Xu; J Kuang; M W Kirschner; G Fischer; L C Cantley; K P Lu
Journal:  Science       Date:  1997-12-12       Impact factor: 47.728

Review 6.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

7.  Crystal structures of substrates and products bound to the phosphoglycerate kinase active site reveal the catalytic mechanism.

Authors:  B E Bernstein; W G Hol
Journal:  Biochemistry       Date:  1998-03-31       Impact factor: 3.162

8.  Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype.

Authors:  Z Duan; D E Lamendola; R Z Yusuf; R T Penson; F I Preffer; M V Seiden
Journal:  Anticancer Res       Date:  2002 Jul-Aug       Impact factor: 2.480

9.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.

Authors:  Ioanna Papandreou; Rob A Cairns; Lucrezia Fontana; Ai Lin Lim; Nicholas C Denko
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

10.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

Authors:  Jung-whan Kim; Irina Tchernyshyov; Gregg L Semenza; Chi V Dang
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

View more
  127 in total

1.  [Expression of phosphoglycerate kinase 1 in endometrial carcinoma and its association with patients' outcome].

Authors:  Li Lin; Qing-Ping Jiang; Dan Lin; Wei Chen; Hui-Ping Jiang; Chun-Hua Liu; Yan-Yi Xiao; Li-Tong Zhu; Sui-Qun Guo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

2.  Co-culture With Human Breast Adipocytes Differentially Regulates Protein Abundance in Breast Cancer Cells.

Authors:  Rebekah Lee Isla Crake; Elisabeth Phillips; Torsten Kleffmann; Margaret Jane Currie
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

3.  PGK1 is a new member of the protein kinome.

Authors:  Xinjian Li; Yanhua Zheng; Zhimin Lu
Journal:  Cell Cycle       Date:  2016-04-22       Impact factor: 4.534

4.  Fructokinase A acts as a protein kinase to promote nucleotide synthesis.

Authors:  Xinjian Li; Xu Qian; Zhimin Lu
Journal:  Cell Cycle       Date:  2016-06-29       Impact factor: 4.534

5.  Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non-Small Cell Lung Cancer.

Authors:  Fei Li; Wai-Lung Ng; Troy A Luster; Hai Hu; Vladislav O Sviderskiy; Catríona M Dowling; Kate E R Hollinshead; Paula Zouitine; Hua Zhang; Qingyuan Huang; Michela Ranieri; Wei Wang; Zhaoyuan Fang; Ting Chen; Jiehui Deng; Kai Zhao; Hon-Cheong So; Alireza Khodadadi-Jamayran; Mousheng Xu; Angeliki Karatza; Val Pyon; Shuai Li; Yuanwang Pan; Kristen Labbe; Christina Almonte; John T Poirier; George Miller; Richard Possemato; Jun Qi; Kwok-Kin Wong
Journal:  Cancer Res       Date:  2020-07-09       Impact factor: 12.701

6.  Phosphoglycerate kinase: structural aspects and functions, with special emphasis on the enzyme from Kinetoplastea.

Authors:  Maura Rojas-Pirela; Diego Andrade-Alviárez; Verónica Rojas; Ulrike Kemmerling; Ana J Cáceres; Paul A Michels; Juan Luis Concepción; Wilfredo Quiñones
Journal:  Open Biol       Date:  2020-11-25       Impact factor: 6.411

Review 7.  Mitochondria and Cancer.

Authors:  Sejal Vyas; Elma Zaganjor; Marcia C Haigis
Journal:  Cell       Date:  2016-07-28       Impact factor: 41.582

Review 8.  Metabolic Kinases Moonlighting as Protein Kinases.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Trends Biochem Sci       Date:  2018-02-17       Impact factor: 13.807

Review 9.  Non-metabolic functions of glycolytic enzymes in tumorigenesis.

Authors:  X Yu; S Li
Journal:  Oncogene       Date:  2016-10-31       Impact factor: 9.867

10.  Aberrant upregulation of PDK1 in ovarian cancer cells impairs CD8+ T cell function and survival through elevation of PD-L1.

Authors:  Jing-Jing Wang; Michelle K Siu; Yu-Xin Jiang; Thomas H Leung; David W Chan; Ran-Ran Cheng; Annie N Cheung; Hextan Y Ngan; Karen K Chan
Journal:  Oncoimmunology       Date:  2019-09-05       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.